Lindenhof AG   Report issue

For profit Phase 4
Founded: Bern Switzerland (2012)
Status: No NME R&D (2012)

Organization Overview

First Clinical Trial
2015
NCT02560155
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Brustzentrum Bern der Lindenhofgruppe | Campus SLB, Lindenhof AG | Lindenhof AG | Lindenhofgruppe | Lindenhofgruppe AG

Active Ingredients

Drugs in Phase 4 Trials (3)

chlorhexidine (hibitane) (2 trials)

mupirocin (bactroban) (2 trials)

vitamin c (1 trial)

Drugs in Other Trials (1)

dibotermin alpha (inductos) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 4)

Infections (Phase 4)

Surgical Wound Infection (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 4